Stock Under $10 with 50-100% upside potential - 14 Days FREE!

AstraZeneca Launches DUTOPROL™ (metoprolol Succinate Extended Release/hydrochlorothiazide) Tablets For High Blood Pressure In U.S.

Stock quotes in this article: AZN 

AstraZeneca (NYSE: AZN) today announced the availability of DUTOPROL™ (metoprolol succinate extended release/hydrochlorothiazide) Tablets, the first and only once-daily antihypertensive agent that contains the active ingredient of TOPROL-XL ® (metoprolol succinate) plus a low-dose diuretic (also known as a water pill) that provides proven blood pressure lowering at 24 hours. 1,2

“One in three US adults have high blood pressure, and of these patients whom are treated, approximately 36% remain uncontrolled,” said Steve Davis, Executive Director, Foundation Brands, AstraZeneca. 4 “DUTOPROL may provide another treatment option for patients with hypertension. We have launched DUTOPROL so patients now have the option to receive a branded combination medicine, in a convenient, once-a-day tablet.”

Instead of a traditional payer contracting strategy, AstraZeneca has taken a novel approach in launching DUTOPROL at a wholesale acquisition price ($15.90) that’s competitive to the generics of TOPROL-XL and hydrochlorothiazide tablets, with or without insurance coverage.

AstraZeneca has created DUTOPROL Direct, a direct-to-patient mail-order program, which may offer additional savings to patients beyond the retail pharmacy price so they can fill their prescription for $18.33 per month, with free shipping and handling, when they order a 90-day supply. However, for patients who wish to use their local pharmacies, AstraZeneca has also created a retail pharmacy program.

With DUTOPROL, AstraZeneca builds upon the hypertension legacy of TOPROL-XL, which has been in use for 20 years as a treatment for hypertension and was among the nation’s top-ten most-prescribed medicines for the five years prior to the introduction of generic versions of TOPROL-XL at all dosage strengths. 5

About DUTOPROL Direct

DUTOPROL Direct is an option that allows eligible patients with a valid prescription for DUTOPROL to have it shipped directly to their home by Express Scripts pharmacy services, for under $20 a month for a 90-day supply.

DUTOPROL Direct does not require a qualification process, nor is a coupon or savings card needed. The program is open to most patients with a valid prescription for DUTOPROL who elect to receive and pay for DUTOPROL on their own. Prescription coverage cannot be used for any type of reimbursement. DUTOPROL Direct is not valid for prescriptions purchased under Medicaid or similar assistance programs.

Patients can submit their enrollment information in two different ways: patients may download the enrollment form from http://www.dutoprol.com/ and then mail in their prescription and enrollment information, or their physician can fax the enrollment form and prescription to 1-800-698-3759.

Patients or physicians with questions can call 1-800-637-3616 to contact DUTOPROL Customer Service between 8:00 AM and 6:00 PM ET, Monday through Friday, excluding holidays.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,335.28 -19.12 -0.12%
NASDAQ 3,496.43 -2.54 -0.07%
S&P 500 1,666.29 -1.18 -0.07%
US 10 Yr 1.965% +0.016

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs